Condition: Tricuspid Regurgitation · Right Heart Failure · Cardiac Remodeling, Ventricular · Sponsor: Helios Klinikum Pforzheim
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
This description comes directly from the study's public registry record.
Ilka Ott, MD, PhD · +4972319692955 · Ilka.Ott@helios-pforzheim.de
Alexandru Patrascu, MD · +491736964480 · alexbasket23@yahoo.com
Always discuss trial participation with your own doctor first.
| Helios Klinikum Pforzheim | Pforzheim, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05179616